With reference to the above captioned subject, we hereby informed you that the Board of Directors at their meeting held today i.e., 14th February 2025, Board Meeting commenced at 05:00 PM. concluded at 6:30 PM at the registered office of the company have considered and approved the following:

pdf

Kabra Drugs Ltd.

07 Feb 2025

Board Meeting

KABRA DRUGS LTD. - 524322 - Board Meeting Intimation for Intimation Of Board Meeting

BSE India

KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company to be held on Friday, 14th February, 2025 at Registered Office at 05.00 p.m. to transact the business as given below: 1.To consider and approve Unaudited financial results for the quarter ending on 31st December, 2024 along with Limited Review Report pursuant to regulation 33 of SEBI (Listed Obligations and Disclosure Requirements) Regulations, 2015; 2.To consider any other matter with the permission of the Chairman of the meeting.

pdf

Kabra Drugs Ltd.

05 Feb 2025

Company Update

KABRA DRUGS LTD. - 524322 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

In furtherance to outcome of Meeting of Allotment committee submitted yesterday ie 4th February 2025 and pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, (Listing Regulations) we would like to intimate that there was unintentional clerical / typographical error in the details of allottees. In view of the same we enclosed herewith the updated outcome of the meeting of allotment committee for your reference

pdf

Kabra Drugs Ltd.

04 Feb 2025

Company Update

KABRA DRUGS LTD. - 524322 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

Announcement under Regulation 30 (LORD) Allotment

pdf

Kabra Drugs Ltd.

04 Feb 2025

Corp. Note

KABRA DRUGS LTD. - 524322 - Board Meeting Outcome for Outcome Of Meeting Of Allotment Committee …

BSE India

Pursuant to Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we would like to intimate that the Board of Directors of Kabra Drugs Limited ('the Company') have, at their meeting held today, i.e., Tuesday, February 04, 2025, at the Registered office of the Company situated at Shop 208, Swadesh Bhavan, 2 Press Complex, AB Road, Indore-452011 the State of Madhya India.

pdf

Kabra Drugs Ltd.

11 Jan 2025

Company Update

KABRA DRUGS LTD. - 524322 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74 (5) of SEBI (DP) Regulation 2018

pdf

No results found

Is Kabra Drugs Ltd. worth buying?

4 Votes:

Buy 50.0%

Sell 25.0%

Hold 25.0%